As of 2025-11-17, the EV/EBITDA ratio of Kuros Biosciences AG (KURN.SW) is -107.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KURN.SW's latest enterprise value is 1,053.59 mil CHF. KURN.SW's TTM EBITDA according to its financial statements is -9.80 mil CHF. Dividing these 2 quantities gives us the above KURN.SW EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 9.5x | 8.8x |
| Forward P/E multiples | 8.4x - 8.9x | 8.6x |
| Fair Price | (1.81) - (1.94) | (1.89) |
| Upside | -106.6% - -107.1% | -106.9% |
| Date | EV/EBITDA |
| 2025-11-14 | -107.48 |
| 2025-11-13 | -106.05 |
| 2025-11-12 | -107.24 |
| 2025-11-11 | -106.21 |
| 2025-11-10 | -104.78 |
| 2025-11-07 | -107.24 |
| 2025-11-06 | -108.59 |
| 2025-11-05 | -112.80 |
| 2025-11-04 | -118.68 |
| 2025-11-03 | -118.45 |
| 2025-10-31 | -117.97 |
| 2025-10-30 | -115.74 |
| 2025-10-29 | -115.35 |
| 2025-10-28 | -114.55 |
| 2025-10-27 | -114.71 |
| 2025-10-24 | -117.17 |
| 2025-10-23 | -119.40 |
| 2025-10-22 | -125.60 |
| 2025-10-21 | -127.10 |
| 2025-10-20 | -126.55 |
| 2025-10-17 | -131.32 |
| 2025-10-16 | -128.38 |
| 2025-10-15 | -123.93 |
| 2025-10-14 | -117.01 |
| 2025-10-13 | -119.16 |
| 2025-10-10 | -114.00 |
| 2025-10-09 | -117.97 |
| 2025-10-08 | -114.79 |
| 2025-10-07 | -111.93 |
| 2025-10-06 | -114.55 |
| 2025-10-03 | -112.01 |
| 2025-10-02 | -108.99 |
| 2025-10-01 | -102.24 |
| 2025-09-30 | -99.93 |
| 2025-09-29 | -94.77 |
| 2025-09-26 | -89.05 |
| 2025-09-25 | -89.13 |
| 2025-09-24 | -94.21 |
| 2025-09-23 | -90.16 |
| 2025-09-22 | -89.92 |
| 2025-09-19 | -91.35 |
| 2025-09-18 | -92.94 |
| 2025-09-17 | -92.62 |
| 2025-09-16 | -91.11 |
| 2025-09-15 | -91.59 |
| 2025-09-12 | -92.15 |
| 2025-09-11 | -92.78 |
| 2025-09-10 | -93.18 |
| 2025-09-09 | -93.18 |
| 2025-09-08 | -97.71 |